Searched over 200M research papers
10 papers analyzed
These studies suggest that angiotensin II is involved in cardiovascular regulation, inflammation, aging, and various physiological processes, including blood pressure control, heart failure progression, and vascular cell functions.
20 papers analyzed
Angiotensin II (Ang II) is a critical hormone in the renin-angiotensin-aldosterone system (RAAS), primarily known for its role in regulating blood pressure and cardiovascular homeostasis. Ang II exerts its effects mainly through the angiotensin II type 1 receptor (AT1R), which mediates vasoconstriction, aldosterone release, and sympathetic nervous system facilitation, all contributing to blood pressure regulation . Additionally, Ang II influences fluid homeostasis by promoting thirst and sodium retention, which are essential for maintaining blood volume and pressure.
Beyond its physiological roles, Ang II is implicated in various pathophysiological processes. It contributes to hypertension, cardiovascular remodeling, and end-organ damage through complex signaling pathways involving AT1R. Ang II also promotes inflammation, oxidative stress, and fibrosis, which are critical in the progression of cardiovascular diseases. The hormone's interaction with other molecules, such as nitric oxide (NO) and transforming growth factor-beta (TGF-β1), further amplifies its pathological effects.
Ang II plays a significant role in aging and age-related diseases. It increases the production of reactive oxygen species (ROS), leading to mitochondrial dysfunction and telomere attrition, which are hallmarks of aging . By binding to AT1R, Ang II exacerbates oxidative stress and inflammation, contributing to the deterioration of organ function and the development of chronic diseases associated with aging.
In the central nervous system (CNS), Ang II regulates several critical functions. It influences body fluid balance, blood pressure, and the release of hormones such as vasopressin and aldosterone. Ang II also interacts with neurotransmitters like catecholamines and serotonin, affecting motivation, memory, and motor control, although these roles are less well understood.
Emerging evidence suggests that Ang II may play a role in cancer. It regulates cell proliferation, angiogenesis, and inflammation, processes that are crucial in tumor progression and metastasis. Ang II type 1 receptor (AT1R) antagonists and angiotensin-converting enzyme (ACE) inhibitors have shown potential in reducing tumor growth and vascularization, highlighting a novel therapeutic avenue in oncology.
The effects of Ang II are mediated by two primary receptors: AT1R and AT2R. While AT1R is responsible for most of the well-known actions of Ang II, including vasoconstriction and inflammation, AT2R often counteracts these effects. AT2R mediates vasodilation, anti-proliferation, and anti-inflammatory responses, primarily through the activation of bradykinin and nitric oxide pathways . This counter-regulatory role of AT2R presents potential therapeutic targets for conditions like hypertension and cardiovascular diseases .
Angiotensin II is a multifaceted hormone with significant roles in cardiovascular regulation, aging, CNS functions, and potentially cancer. Its diverse effects are mediated through complex signaling pathways involving AT1R and AT2R. Understanding these pathways offers promising therapeutic strategies for various diseases, emphasizing the importance of continued research in this field.
Most relevant research papers on this topic